-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:1.
75em;box-sizing:border-box ;overflow-wrap:break-word ;'>
544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:1.
75em;box-sizing:border-box ;overflow-wrap:break-word ;'> Today, Pfizer and BioNTech jointly announced that the new crown vaccine BNT162b2 jointly developed by the two parties has shown 100% efficacy and a strong antibody immune response in a phase 3 clinical trial conducted in adolescents aged 12-15 .
The two companies plan to submit these data to the US FDA and other regulatory agencies around the world, hoping to initiate vaccination for this group of young people before the start of the new school year.
The two companies plan to submit these data to the US FDA and other regulatory agencies around the world, hoping to initiate vaccination for this group of young people before the start of the new school year.
The new crown vaccine BNT162b2 demonstrated 100% efficacy and a strong antibody immune response in a phase 3 clinical trial conducted in adolescents aged 12-15544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:1.
75em;box-sizing:border-box ;overflow-wrap:break-word ;'>
544px;white-space:normal;background-color:#FFFFFF;text-align:center;box-sizing:border-box ;'>
544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:1.75em;box-sizing:border-box ;overflow-wrap:break-word ;'>544px;text-align:justify;white-space:normal;background-color:#FFFFFF;line-height:1.
75em;box-sizing:border-box ;overflow-wrap:break-word ;'>BNT162b2 is a new coronavirus vaccine based on mRNA technology.
Not only does it show up to 95% preventive efficacy in clinical trials conducted in adults and the elderly, but the protective effect produced by vaccination in the weixin.
qq.
com/s?__biz=MzAwMDA5NTIxNQ==&mid=2650003098&idx=4&sn=58cf1b3f89bfcc88f5315d3b38f51f6a&scene=21#wechat_redirect" textvalue="" tab="innerlink" data-linktype="2" style="margin:0px;padding:0px;color:#576B95;text-decoration-line:none;-webkit-tap-highlight-color:rgba(0, 0, 0, 0);cursor:pointer;max-width:100%;box-sizing:border-box ;overflow-wrap:break-word ;">real world is also over 90%.
544px;white-space:normal;background-color:#FFFFFF;line-height:1.
75em;text-align:center;box-sizing:border-box ;overflow-wrap:break-word ;'>Image source: 123RF